On January 03, 2025, the Stochastic Oscillator for KNSA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on KNSA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 50-day moving average for KNSA moved below the 200-day moving average on January 03, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for KNSA entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KNSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.091) is normal, around the industry mean (15.017). P/E Ratio (164.538) is within average values for comparable stocks, (88.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.838). KNSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (3.546) is also within normal values, averaging (265.166).
a manufacturer of pharmaceutical products
Industry Biotechnology
A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with FATE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then FATE could also see price increases.
Ticker / NAME | Correlation To KNSA | 1D Price Change % | ||
---|---|---|---|---|
KNSA | 100% | +0.92% | ||
FATE - KNSA | 44% Loosely correlated | +3.94% | ||
ABVC - KNSA | 40% Loosely correlated | +0.22% | ||
NTLA - KNSA | 40% Loosely correlated | +4.63% | ||
TRDA - KNSA | 39% Loosely correlated | +2.92% | ||
BEAM - KNSA | 39% Loosely correlated | +4.65% | ||
More |
Ticker / NAME | Correlation To KNSA | 1D Price Change % |
---|---|---|
KNSA | 100% | +0.92% |
Pharmaceuticals category (309 stocks) | 26% Poorly correlated | +1.37% |